FDA Inspection 1167494 — Eli Lilly S.A. (Irish Branch)
The FDA completed an inspection of Eli Lilly S.A. (Irish Branch) on March 15, 2022 in Kinsale. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 15, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Kinsale (Ireland)